| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Tumor Immunology and Biology, National Cancer Institute [D. G., E. K., R. C., G. H. S.], Laboratory of Molecular Biology, National Cancer Institute [C. J., R. S., G. M.], and Laboratory of Metabolism and Biochemistry, National Institute of Diabetes and Digestive and Kidney Diseases [G. R., L. H.], NIH, Bethesda, Maryland 20892
Insertional mutation of the Int3 gene, a member of the Notch gene family, is frequently associated with primary mouse mammary tumors induced by the mouse mammary tumor virus (MMTV). A major consequence of these mutations is the production of a shortened 2.4-kb tumorspecific Int3 RNA transcript that encodes the entire intracellular domain of the Int3 protein. Previous studies have demonstrated that mammary gland development and function was severely impaired in transgenic mice expressing the truncated Int3 gene product from the MMTV viral promoter. Both mammary ductal growth and secretory lobule development were curtailed in these mice. These results were attributed to a gain of function modification of the Int3 gene, which led to a restriction of cell fate selection in the affected mammary epithelial cells. To confirm and extend these findings, truncated Int3 was expressed from the whey acidic protein (WAP) promoter, the activity of which, unlike that of the MMTV long terminal repeat, is restricted to the secretory mammary epithelial population. In transgenic mice carrying the WAP/Int3 construct, mammary ductal growth was unaffected in virgin females, but growth and differentiation of secretory lobules during gestation was profoundly inhibited. Coincidental with the block in lobular secretory differentiation, mammary dysplasia and tumorigenesis occurred in all breeding females by 25 weeks of age. In nonbreeding WAP/Int3 females, mammary tumor incidence also reached 100%, but only after 70 weeks. The WAP/Int3 mammary tumors were highly malignant, and most tumor-bearing females, irrespective of breeding history, developed metastatic lung lesions. These results suggest that WAP promoter-targeted Int3 function is associated with mammary secretory cell differentiation and maintenance in this transgenic model. Consistent with the conclusion that WAP-driven truncated Int3 expression influenced only lobular differentiation and not ductal growth and extension during mammary gland development, transplants of WAP/Int3 gland into nontransgenic mammary fat pads produced complete mammary ductal outgrowths in virgin FVB/N mice but failed to develop secretory lobules when the females were impregnated.
1 To whom requests for reprints should be addressed, at Building 10, Room 8B07, National Cancer Institute, NIH, Bethesda, MD 20892-1750.
Received 10/ 6/95. Accepted 2/14/96.
This article has been cited by other articles:
|
|
 |
|
  T. Dai Notch Signaling and Cancer Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 71 - 79. [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Leong, K. Niessen, I. Kulic, A. Raouf, C. Eaves, I. Pollet, and A. Karsan Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin J. Exp. Med., November 26, 2007; 204(12): 2935 - 2948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bolos, J. Grego-Bessa, and J. L. de la Pompa Notch Signaling in Development and Cancer Endocr. Rev., May 1, 2007; 28(3): 339 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wu and E. H. Bresnick Glucocorticoid and Growth Factor Synergism Requirement for Notch4 Chromatin Domain Activation Mol. Cell. Biol., March 15, 2007; 27(6): 2411 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gonzalez-Suarez, D. Branstetter, A. Armstrong, H. Dinh, H. Blumberg, and W. C. Dougall RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia and Disrupts Lumen Formation in Cultured Epithelial Acini Mol. Cell. Biol., February 15, 2007; 27(4): 1442 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Leong and A. Karsan Recent insights into the role of Notch signaling in tumorigenesis Blood, March 15, 2006; 107(6): 2223 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hu, A. Dievart, M. Lupien, E. Calvo, G. Tremblay, and P. Jolicoeur Overexpression of Activated Murine Notch1 and Notch3 in Transgenic Mice Blocks Mammary Gland Development and Induces Mammary Tumors Am. J. Pathol., March 1, 2006; 168(3): 973 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Reedijk, S. Odorcic, L. Chang, H. Zhang, N. Miller, D. R. McCready, G. Lockwood, and S. E. Egan High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survival Cancer Res., September 15, 2005; 65(18): 8530 - 8537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jia, C. Qi, Z. Zhang, Y. T. Zhu, S. M. Rao, and Y.-J. Zhu Peroxisome Proliferator-activated Receptor-binding Protein Null Mutation Results in Defective Mammary Gland Development J. Biol. Chem., March 18, 2005; 280(11): 10766 - 10773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pece, M. Serresi, E. Santolini, M. Capra, E. Hulleman, V. Galimberti, S. Zurrida, P. Maisonneuve, G. Viale, and P. P. Di Fiore Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis J. Cell Biol., October 25, 2004; 167(2): 215 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Qi, P. Kashireddy, Y. T. Zhu, S. M. Rao, and Y.-J. Zhu Null Mutation of Peroxisome Proliferator-activated Receptor-interacting Protein in Mammary Glands Causes Defective Mammopoiesis J. Biol. Chem., August 6, 2004; 279(32): 33696 - 33701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kiaris, K. Politi, L. M. Grimm, M. Szabolcs, P. Fisher, A. Efstratiadis, and S. Artavanis-Tsakonas Modulation of Notch Signaling Elicits Signature Tumors and Inhibits Hras1-Induced Oncogenesis in the Mouse Mammary Epithelium Am. J. Pathol., August 1, 2004; 165(2): 695 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wang, Y. E. Liu, I. D. Goldberg, and Y. E. Shi Induction of Mammary Gland Differentiation in Transgenic Mice by the Fatty Acid-binding Protein MRG J. Biol. Chem., November 21, 2003; 278(47): 47319 - 47325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Montagna, M.-S. Lyu, K. Hunter, L. Lukes, W. Lowther, T. Reppert, B. Hissong, Z. Weaver, and T. Ried The Septin 9 (MSF) Gene Is Amplified and Overexpressed in Mouse Mammary Gland Adenocarcinomas and Human Breast Cancer Cell Lines Cancer Res., May 1, 2003; 63(9): 2179 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu, T. Sun, K. Kobayashi, P. Gao, and J. D. Griffin Identification of a Family of Mastermind-Like Transcriptional Coactivators for Mammalian Notch Receptors Mol. Cell. Biol., November 1, 2002; 22(21): 7688 - 7700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jeffries, D. J. Robbins, and A. J. Capobianco Characterization of a High-Molecular-Weight Notch Complex in the Nucleus of Notchic-Transformed RKE Cells and in a Human T-Cell Leukemia Cell Line Mol. Cell. Biol., June 1, 2002; 22(11): 3927 - 3941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Vollrath, J. Pudney, S. Asa, P. Leder, and K. Fitzgerald Isolation of a Murine Homologue of the Drosophila neuralized Gene, a Gene Required for Axonemal Integrity in Spermatozoa and Terminal Maturation of the Mammary Gland Mol. Cell. Biol., November 1, 2001; 21(21): 7481 - 7494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ansieau, L. J. Strobl, and A. Leutz Activation of the Notch-regulated transcription factor CBF1/RBP-J{kappa} through the 13SE1A oncoprotein Genes & Dev., February 15, 2001; 15(4): 380 - 385. [Abstract] [Full Text]
|
|
|
|
|
|
S. Jeffries and A. J. Capobianco Neoplastic Transformation by Notch Requires Nuclear Localization Mol. Cell. Biol., June 1, 2000; 20(11): 3928 - 3941. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Lin, C Leimeister, M Gessler, and R Kopan Activation of the Notch pathway in the hair cortex leads to aberrant differentiation of the adjacent hair-shaft layers Development, January 6, 2000; 127(11): 2421 - 2432. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
